Combined Ascending Aortic Stent-Graft and Inner Branched Arch Device for Type A Aortic Dissection.
Publisher DOI
PubMed ID
30068255
Abstract
PURPOSE
To report the use of the Zenith Ascend stent-graft in conjunction with the Zenith inner branched arch device to treat type A aortic dissection.
CASE REPORT
Five patients (mean age 66 years, range 52-78; 4 men) with type A aortic dissection (2 acute) and insufficient distal landing zones were treated with the Zenith Ascend stent-graft and inner branched arch devices to extend the distal landing zone. Left carotid-subclavian bypass was performed in a staged or simultaneous setting depending on the urgency of the condition. Technical success (no type I or III endoleak and successful revascularization of all supra-aortic vessels) was achieved in all patients. Median intensive care unit stay was 5 days (range 4-23) and the median hospital stay was 16 days (range 8-25). The 2 patients with acute dissection died in hospital and at 5 months, respectively. The 3 elective patients were followed for 7, 13, and 19 months, respectively. All had false lumen thrombosis with either a reduced or stable aneurysm diameter.
CONCLUSION
This limited experience demonstrated the feasibility and safety of the combined use of the Ascend stent-graft and inner branched arch devices. This strategy may sometimes be more beneficial than either stent-graft used alone.
To report the use of the Zenith Ascend stent-graft in conjunction with the Zenith inner branched arch device to treat type A aortic dissection.
CASE REPORT
Five patients (mean age 66 years, range 52-78; 4 men) with type A aortic dissection (2 acute) and insufficient distal landing zones were treated with the Zenith Ascend stent-graft and inner branched arch devices to extend the distal landing zone. Left carotid-subclavian bypass was performed in a staged or simultaneous setting depending on the urgency of the condition. Technical success (no type I or III endoleak and successful revascularization of all supra-aortic vessels) was achieved in all patients. Median intensive care unit stay was 5 days (range 4-23) and the median hospital stay was 16 days (range 8-25). The 2 patients with acute dissection died in hospital and at 5 months, respectively. The 3 elective patients were followed for 7, 13, and 19 months, respectively. All had false lumen thrombosis with either a reduced or stable aneurysm diameter.
CONCLUSION
This limited experience demonstrated the feasibility and safety of the combined use of the Ascend stent-graft and inner branched arch devices. This strategy may sometimes be more beneficial than either stent-graft used alone.
Date Issued
2018-10
Publication Type
Article
Subject(s)
Subjects
aortic arch aortic arch aneurysm branched arch stent-graft endograft inner branched stent-graft thoracic endovascular aortic repair type A aortic dissection
Language(s)
en
Author(s)
Law, Yuk | |
Tsilimparis, Nikolaos | |
Rohlffs, Fiona | |
Debus, E Sebastian | |
Kölbel, Tilo |
Additional Credits
Journal
Journal of endovascular therapy
Publisher
International Society of Endovascular Specialists
ISSN
1526-6028
Access(Rights)
metadata.only